key: cord-0962197-lozkrca3
authors: Gou, W.; Fu, Y.; Yue, L.; Chen, G.-d.; Cai, X.; Shuai, M.; Xu, F.; Yi, X.; Chen, H.; Zhu, Y. J.; Xiao, M.-l.; Jiang, Z.; Miao, Z.; Xiao, C.; Shen, B.; Wu, X.; Zhao, H.; Ling, W.; Wang, J.; Chen, Y.-m.; Guo, T.; Zheng, J.-S.
title: Gut microbiota may underlie the predisposition of healthy individuals to COVID-19
date: 2020-04-25
journal: nan
DOI: 10.1101/2020.04.22.20076091
sha: 9718eeee44736c9aa9a129ee616c8a001ac56bec
doc_id: 962197
cord_uid: lozkrca3

The COVID-19 pandemic is spreading globally with high disparity in the susceptibility of the disease severity. Identification of the key underlying factors for this disparity is highly warranted. Here we describe constructing a proteomic risk score based on 20 blood proteomic biomarkers which predict the progression to severe COVID-19. We demonstrate that in our own cohort of 990 individuals without infection, this proteomic risk score is positively associated with proinflammatory cytokines mainly among older, but not younger, individuals. We further discovered that a core set of gut microbiota could accurately predict the above proteomic biomarkers among 301 individuals using a machine learning model, and that these gut microbiota features are highly correlated with proinflammatory cytokines in another set of 366 individuals. Fecal metabolomic analysis suggested potential amino acid-related pathways linking gut microbiota to inflammation. This study suggests that gut microbiota may underlie the predisposition of normal individuals to severe COVID-19.

With the coronavirus disease 2019 (COVID-19) defined as 'global pandemic ' and 18 spreading worldwide at an unprecedented speed, more than two million individuals 19 have been infected globally since its first detection in December 2019 to mid-April CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. Table S1 ). Based on the COVID-19 patient data, we constructed a blood proteomic (Table S2) . We only used 20 of the 22 proteins for our PRS construction 73 because 2 proteins were unavailable in our large proteomics database among 74 non-infected participants for the further analysis. Among the COVID-19 patients, 75 Poisson regression analysis indicated that per 10% increment in the PRS there was 76 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. . https://doi.org/10.1101/2020.04.22.20076091 doi: medRxiv preprint 5 associated a 57% higher risk of progressing to clinically severe phase (RR, 1.57; 95% 77 CI, 1.35-1.82; Figure 2A ), in support of the PRS as being a valid proxy for the 78 predictive biomarkers of severe COVID-19.

To explore the potential implication of the PRS among non-COVID-19 individuals, 81 we constructed the PRS using the same set of 20 blood proteins among a cohort of 82 non-infected participants with data of both proteomics and inflammatory markers 83 (n=990). The blood proteomic data was based on the baseline serum samples of the 84 cohort ( Figure S1 ). We investigated the correlation between the PRS and blood To investigate the potential role of gut microbiota in the susceptibility of healthy 103 individuals to COVID-19, we next explored the relationship between the gut 104 microbiota and the above COVID-19-related PRS in a sub-cohort of 301 participants 105 with measurement of both gut microbiota (16s rRNA) and blood proteomics data 106 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 25, 2020. . https://doi.org/10.1101/2020.04.22.20076091 doi: medRxiv preprint 6 ( Figure S1 ). Gut microbiota data were collected and measured during a follow-up 107 visit of the cohort participants, with a cross-sectional subset of the individuals (n=132) 108 having blood proteomic data at the same time point as the stool collection and another 109 independent prospective subset of the individuals (n=169) having proteomic data at a 110 next follow-up visit ~3 years later than the stool collection. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 25, 2020. Pearson's r of 0.18 between the core OTUs-predicted PRS versus actual PRS (p<0.05), 137 also outperforming the predictive capacity of the above demographic characteristics 138 and laboratory tests (Pearson's r =0.08, p=0.31) ( Figure 3A ). These findings support 139 that change in the gut microbiota may precede the change in the blood proteomic 140 biomarkers, inferring a potential causal relationship. Fecal metabolome may be the key to link the PRS-related core microbial features 153 and host inflammation 154 We hypothesized that the influences of the core microbial features on the PRS and 155 host inflammation were driven by some specific microbial metabolites. So we 156 assessed the relationship between the core gut microbiota and fecal metabolome 157 among 987 participants, whose fecal metabolomics and 16s rRNA microbiome data 158 were collected and measured at the same time point during the follow-up visit of the 159 participants ( Figure S1 ). After correction for the multiple testing (FDR<0.05), a total 166 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 25, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 25, 2020. analysis reveals that amino acid-related pathway may provide the key link between 199 the identified core gut microbiota, inflammation and COVID-19 susceptibility. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 25, 2020. In the present study, the core gut microbial features (20 OTUs), with a satisfied 226 performance, outperform demographic characteristics and laboratory tests in 227 predicting the blood proteomic biomarkers, which highlights a potential role of gut 228 microbiota in regulating the susceptibility of COVID-19 among normal individuals.

In fact, maintaining gut homeostasis has been suggested as a treatment option in the CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. 

The authors declare no competing financial interests 315 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. venous whole blood in the early morning before diet using serum separation tubes.

The blood samples were centrifuged at 3,500 rpm for 10 min for serum collection. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. inter-ran CVs are typically below 15%. In the present study, the inters-run CVs of 501 calibrators were 2.2% for IL-1β, 2.5% for IL-2, 1.6% for IL-4, 1.7 for IL-6, 3.6 for 502 IL-8, 2.5 for 1.3% for IL-10, 1.1% for IL-12p70, 0.87% for IL-13, TNF-α, 2.0% for 503 IFN-γ. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. The ultimate goal of QA/QC is to provide the reliable data for biomarker discovery 593 study and/ or to aid molecular biology research. To achieve this, three types of quality are commonly processed using the same procedures as the samples to be analyzed.

The reagent blanks serve as a useful alert to systematic contamination. As the reagent 618 blanks consist of high purity solvents and are analyzed using the same methods as the 619 study samples, they are also used to wash the column and remove cumulative matrix 620 effects throughout the study. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. Correlation between PRS and pro-inflammatory biomarkers 715 Spearman correlation analysis was used to examine the correlation between PRS and 716 pro-inflammatory biomarkers (i.e., hsCRP, IL-1β, IL-6 and TNF-α). p<0.05 was 717 considered as statistically significant. In this approach, each LightGBM model is trained on 90% of the cohort with 10-fold 725 CV, and PRS is predicted for the 10% of the participants who were not used for model 726 optimization. This process is repeated ten-fold resulting in a test PRS set for each 727 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. Table S1 . Characteristics of the data analysis sets . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. Figure S1 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. Figure S2 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. Figure S3 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 25, 2020. that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C9 is the pore-forming subunit of the MAC;

Belongs to the complement C6/C7/C8/C9 family P01011 GIG25 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3;

Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2; Serpin peptidase inhibitors P00751 CFB Complement factor B; Factor B which is part of the alternate pathway of the complement system is cleaved by factor D into 2 fragments: Ba and Bb. Bb, a serine protease, then combines with complement factor 3b to generate the C3 or C5

convertase. It has also been implicated in proliferation and differentiation of preactivated B-lymphocytes, rapid spreading of peripheral blood monocytes, stimulation of lymphocyte blastogenesis and lysis of erythrocytes. Ba inhibits the proliferation of preactivated B-lymphocytes; Belongs to the peptidase S1 family P00738 HP Haptoglobin; As a result of hemolysis, hemoglobin is found to accumulate in the kidney and is secreted in the urine. Haptoglobin captures, and combines with free plasma hemoglobin to allow hepatic recycling of heme iron and to prevent kidney damage. Haptoglobin also acts as an Antimicrobial; Antioxidant, has antibacterial activity and plays a role in modulating many aspects of the acute phase response.

Hemoglobin/haptoglobin complexes are rapidely cleared by the macrophage CD163 scavenger receptor expressed on the surface of liver Kupfer cells through an endocytic lysosomal degradation.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 25, 2020. g__Bacteroides; s__ . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 25, 2020. . https://doi.org/10.1101/2020.04.22.20076091 doi: medRxiv preprint

Role of the microbiota in immunity and 798 inflammation

Ribosome-dependent activation of stringent control

Mammalian aminoacyl-tRNA 802 synthetases: cell signaling functions of the protein translation machinery

Metformin retards 806 aging in C. elegans by altering microbial folate and methionine metabolism

Gut microbiota-mediated inflammation in obesity: 809 a link with gastrointestinal cancer

QIIME allows 813 analysis of high-throughput community sequencing data

Epidemiological and clinical characteristics of 99 cases of 2019 816 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Comprehensive and Integrative Metabolomics Data Analysis. Current Protocols in 820

Emerging Targets for Cardiopulmonary Disease Therapy

Current understanding of the human microbiome

a Values are numbers (percentages) or mean (SD)

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 25, 2020. Shen, B., Yi, X., Sun, Y., Bi, X., Du, J., Zhang, C., Quan, S., Zhang, F., Sun, R., Qian,